exp3174 has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies
| Studies (exp3174) | Trials (exp3174) | Recent Studies (post-2010) (exp3174) | Studies (6-ketoprostaglandin f1 alpha) | Trials (6-ketoprostaglandin f1 alpha) | Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha) |
|---|---|---|---|---|---|
| 236 | 29 | 43 | 4,832 | 294 | 150 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busse, R; Fisslthaler, B; Fleming, I; Schini-Kerth, VB | 1 |
1 other study(ies) available for exp3174 and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Thrombin receptor expression is increased by angiotensin II in cultured and native vascular smooth muscle cells.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Blotting, Northern; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Indoles; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Polymerase Chain Reaction; Protein Kinase C; Rats; Rats, Wistar; Receptors, Thrombin; RNA, Messenger; Tetrazoles; Thrombin | 1998 |